New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
15:12 EDTPGProcter & Gamble technical notes ahead of earnings
In the prior three months the stock has underperformed the broader averages, falling by over 5% in that time. The trading range as is typical for the shares has been relatively narrow. At the low the range is at $78.50 and at the high at $82.50. A breakout above the top of the range would resolve bullishly with next resistance at the 52-week high at $85.82. As that is the life high as well, a next objective might be at the $87 area, but that would be an exceptional move for the stock given its history. With the stock currently trading just below the three month range lows, next supports as potential downside objectives would be at $76.09, near six month lows, and then at $73.61 which is the 52-week low. An exceptional downside move on a major disappointment could push shares to $70.66. That area was previously resistance in late 2012 and early 2013. While such a move may seem like an extreme outlier, a look at a 5-year chart shows the potential for the last two years of prices movement to be a complex head and shoulders top.
News For PG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
10:28 EDTPGProcter & Gamble, Hasbro face tax probe in Mexico, Reuters says
Mexico's Oscar Molina, who previously said seven multinationals were the focus of a government probe of companies that may have been exploiting loopholes to avoid paying sufficient taxes, has now said he is in advanced discussions with two companies to pay more tax for prior years, and five sources have told Reuters those two are Procter & Gamble (PG) and Hasbro (HAS). Reference Link
September 24, 2014
06:42 EDTPGMore e-commerce start-ups undercutting established firms, NY Times says
Subscribe for More Information
September 23, 2014
09:01 EDTPGDistrict court rules in favor of P&G on patent infringement case
In a series of rulings this summer, culminating with a ruling issued on September 15th, the federal District Court for the Southern District of Ohio ruled that Clio USA’s tooth whitening strip products infringe several P&G patents related to P&G’s Crest Whitestrips products. The Court also rejected Clio’s arguments that the patents are invalid.
08:00 EDTPGSpectrum Brands to acquire P&G's European pet food business
Procter & Gamble (PG) announced that Spectrum Brands (SPB) has agreed to buy IAMS and EUKANUBA brands in Europe for an undisclosed amount. In April, P&G announced the sale to Mars of 80% of its global Pet Care business, including North America and Latin America. Europe was not included in that deal with the exception of Russia and Turkey. Mars later agreed to buy an additional 10% of the business in additional markets including Japan, Australia and South Africa. With the Spectrum transaction, P&G now has closed deals or reached agreements to sell 100% of its Pet Care business. The deal will close in 2015, subject to regulatory approvals. The geographic regions included in the acquisition, which account for approximately 10% of P&G’s former pet care global sales, include 42 markets throughout Europe. The business has approximately $200M of annual sales and will provide Spectrum Brands’ United Pet Group division access to the $21B European dog and cat food market which is growing at an estimated 3%-5% annually. The acquisition has been approved by Spectrum Brands' board.
September 20, 2014
22:05 EDTPGClorox turned down offer to sell or merge with rival, NY Post says
In the last three to six months consumer packaged-goods company Clorox (CLX) turned down an offer from a rival interested in a sale or merger, says the NY Post, citing sources. The NY Post added that logical suitors for Clorox include Church & Dwight (CHD), Procter & Gamble (PG), Jarden (JAH) and Unilever (UN,UL). Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use